Lord, Abbett & Co’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $60.6M | Buy |
1,403,741
+545,819
| +64% | +$23.6M | 0.2% | 131 |
|
|
2025
Q1 | $29.7M | Buy |
+857,922
| New | +$29.7M | 0.11% | 226 |
|
|
2024
Q2 | – | Sell |
-2,804,394
| Closed | -$86.7M | – | 523 |
|
|
2024
Q1 | $86.7M | Sell |
2,804,394
-293,688
| -9% | -$9.08M | 0.28% | 109 |
|
|
2023
Q4 | $125M | Buy |
3,098,082
+2,303,681
| +290% | +$93M | 0.44% | 66 |
|
|
2023
Q3 | $20.9M | Buy |
+794,401
| New | +$20.9M | 0.08% | 318 |
|
|
2021
Q4 | – | Sell |
-796,668
| Closed | -$37.3M | – | 606 |
|
|
2021
Q3 | $37.3M | Sell |
796,668
-25,350
| -3% | -$1.19M | 0.09% | 325 |
|
|
2021
Q2 | $50.1M | Sell |
822,018
-408,867
| -33% | -$24.9M | 0.12% | 258 |
|
|
2021
Q1 | $75.8M | Buy |
1,230,885
+156,919
| +15% | +$9.67M | 0.19% | 168 |
|
|
2020
Q4 | $76.4M | Buy |
1,073,966
+459,242
| +75% | +$32.7M | 0.2% | 158 |
|
|
2020
Q3 | $23.1M | Sell |
614,724
-316,009
| -34% | -$11.9M | 0.07% | 353 |
|
|
2020
Q2 | $30.4M | Sell |
930,733
-58,534
| -6% | -$1.91M | 0.11% | 296 |
|
|
2020
Q1 | $28.7M | Buy |
989,267
+30,083
| +3% | +$872K | 0.13% | 253 |
|
|
2019
Q4 | $33.6M | Buy |
959,184
+158,380
| +20% | +$5.55M | 0.11% | 286 |
|
|
2019
Q3 | $17.2M | Buy |
800,804
+307,462
| +62% | +$6.6M | 0.06% | 432 |
|
|
2019
Q2 | $13.3M | Buy |
+493,342
| New | +$13.3M | 0.04% | 500 |
|